Histone H2A (acetyl K9) (4G2) Monoclonal Antibody

$Lane 1: HeLa treated with 500 ng\/ml Trichostatin A for 4 hours whole cell lysates; Lane 2: Untreated HeLa whole cell lysates probed with Histone H2A(acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:500 and unmodified Histone H2A.X antibody as control, incubated overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.$

Lane 1: HeLa treated with 500 ng\/ml Trichostatin A for 4 hours whole cell lysates; Lane 2: Untreated HeLa whole cell lysates probed with Histone H2A(acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:500 and unmodified Histone H2A.X antibody as control, incubated overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.

$IF(ICC) staining with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100 in HeLa cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100\/PBS.$

IF(ICC) staining with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100 in HeLa cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100\/PBS.

$IF(ICC) staining with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100 in A549 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100\/PBS.$

IF(ICC) staining with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100 in A549 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100\/PBS.

$IF(ICC) staining with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100 in MCF-7 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100\/PBS.$

IF(ICC) staining with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100 in MCF-7 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100\/PBS.

$Paraformaldehyde-fixed and paraffin-embedded Human breast carcinoma tissue incubated with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Human breast carcinoma tissue incubated with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

$Paraformaldehyde-fixed and paraffin-embedded Human tonsil tissue incubated with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Human tonsil tissue incubated with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

$Paraformaldehyde-fixed and paraffin-embedded Mouse testis tissue incubated with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Mouse testis tissue incubated with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

$Paraformaldehyde-fixed and paraffin-embedded Human lung carcinoma tissue incubated with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Human lung carcinoma tissue incubated with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

$Paraformaldehyde-fixed and paraffin-embedded Mouse thyroid tissue incubated with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Mouse thyroid tissue incubated with Histone H2A (acetyl K9) (4G2) Monoclonal Antibody (bsm-52285R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

Applications

WB
IHC-P
IF(ICC)
IHC

Reactivity

Human
Mouse
Rat

Overview
Catalog #	bsm-52285R
Product Name	Histone H2A (acetyl K9) (4G2) Monoclonal Antibody
Applications	WB IHC-P IF(ICC) IHC
Reactivity	Human, Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	Synthetic peptide surrounding K9 of Histone H2A
Modification Site	acetyl K9
Clonality	Monoclonal
Clone #	4G2
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Store at -20C for 12 months.
Target
Gene ID	3012, 8335
Swiss Prot	P04908
Subcellular location	Nucleus
Synonyms	Histone H2A type 1-B/E, Histone H2A.2, Histone H2A/a, Histone H2A/m, Histone H2A type 1-C, Histone H2A/l, Histone H2A type 1-J, Histone H2A/e, HIST1H2AB, HIST1H2AC, HIST1H2AJ
Background	Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.
Application Dilution
WB	1:300-5000
IHC-P	1:200-400
IF(ICC)	1:50-200
IHC